GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | CYP1B1 | affects expression | EXP | | 6480464 | CTD | resveratrol affects the expression of CYP1B1 protein | PMID:15893423 | CYP1B1 | affects metabolic processing | EXP | | 6480464 | CTD | CYP1B1 protein affects the metabolism of resveratrol | PMID:15276085 | CYP1B1 | decreases activity | EXP | | 6480464 | CTD | resveratrol results in decreased activity of CYP1B1 protein | PMID:11714871 | CYP1B1 | decreases expression | EXP | | 6480464 | CTD | resveratrol results in decreased expression of CYP1B1; resveratrol results in decreased expression of CYP1B1 mRNA; resveratrol results in decreased expression of CYP1B1 protein | PMID:11279601 PMID:14990334 PMID:15182955 PMID:15280659 PMID:15316568 | CYP1B1 | multiple interactions | EXP | | 6480464 | CTD | [Coumestrol co-treated with Resveratrol] results in increased expression of CYP1B1 mRNA; Resveratrol binds to and results in decreased activity of CYP1B1 protein; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of CYP1B1 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1B1 protein]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; Resveratrol inhibits the reaction [CYP1B1 protein affects the chemical synthesis of 4-hydroxyestradiol]; Resveratrol inhibits the reaction [CYP1B1 protein affects the metabolism of Estradiol]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to CYP1B1 promoter]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1B1 enhancer]]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein] | PMID:11279601 PMID:15142886 PMID:15162144 PMID:16484233 PMID:19138946 PMID:19167446 PMID:19376845 PMID:19563207 PMID:20846786 PMID:29209748 PMID:29876539 | CYP1B1 | decreases activity | ISO | Cyp1b1 (Mus musculus) | 6480464 | CTD | resveratrol results in decreased activity of CYP1B1 protein | PMID:18420780 PMID:19329757 | CYP1B1 | multiple interactions | ISO | Cyp1b1 (Mus musculus) | 6480464 | CTD | [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Resveratrol co-treated with Benzo(a)pyrene] results in decreased expression of CYP1B1 protein; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] | PMID:18694800 PMID:20103723 PMID:30165701 | |
Go Back to source page | Continue to Ontology report |